187 related articles for article (PubMed ID: 28414203)
1. Self-assembled nanocomplex between polymerized phenylboronic acid and doxorubicin for efficient tumor-targeted chemotherapy.
Lee J; Kim J; Lee YM; Park D; Im S; Song EH; Park H; Kim WJ
Acta Pharmacol Sin; 2017 Jun; 38(6):848-858. PubMed ID: 28414203
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide-loaded polymerized phenylboronic acid nanoconstruct for stimuli-responsive chemotherapy.
Kim J; Lee J; Lee YM; Pramanick S; Im S; Kim WJ
J Control Release; 2017 Aug; 259():203-211. PubMed ID: 27984106
[TBL] [Abstract][Full Text] [Related]
3. Phenylboronic acid conjugated to doxorubicin nanocomplexes as an anti-cancer drug delivery system in hepatocellular carcinoma.
Kang BY; Hur W; Kim SM; Kim S; Lee J; Tak E; Kim WJ; Chun HJ; Yoon SK
Nanomedicine; 2021 Jun; 34():102389. PubMed ID: 33753281
[TBL] [Abstract][Full Text] [Related]
4. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of doxorubicin-loaded 3-helix micelles as nanocarriers.
Dube N; Shu JY; Dong H; Seo JW; Ingham E; Kheirolomoom A; Chen PY; Forsayeth J; Bankiewicz K; Ferrara KW; Xu T
Biomacromolecules; 2013 Oct; 14(10):3697-705. PubMed ID: 24050265
[TBL] [Abstract][Full Text] [Related]
6. Dual-acidity-labile polysaccharide-di-drugs conjugate for targeted cancer chemotherapy.
Li D; Su T; Ma L; Yin F; Xu W; Ding J; Li Z
Eur J Med Chem; 2020 Aug; 199():112367. PubMed ID: 32474350
[TBL] [Abstract][Full Text] [Related]
7. The synergistic effect and mechanism of doxorubicin-ZnO nanocomplexes as a multimodal agent integrating diverse anticancer therapeutics.
Deng Y; Zhang H
Int J Nanomedicine; 2013; 8():1835-41. PubMed ID: 23674895
[TBL] [Abstract][Full Text] [Related]
8. Phenylboronic acid-modified polymaleic anhydride-F127 micelles for pH-activated targeting delivery of doxorubicin.
Feng R; Zhu L; Teng F; Wang M; Chen S; Song Z; Li H
Colloids Surf B Biointerfaces; 2022 Aug; 216():112559. PubMed ID: 35576880
[TBL] [Abstract][Full Text] [Related]
9. H
Xu Y; Shi W; Li H; Li X; Ma H
ChemMedChem; 2019 Jun; 14(11):1079-1085. PubMed ID: 30908865
[TBL] [Abstract][Full Text] [Related]
10. Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors.
Deshayes S; Cabral H; Ishii T; Miura Y; Kobayashi S; Yamashita T; Matsumoto A; Miyahara Y; Nishiyama N; Kataoka K
J Am Chem Soc; 2013 Oct; 135(41):15501-7. PubMed ID: 24028269
[TBL] [Abstract][Full Text] [Related]
11. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers.
Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H
Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983
[TBL] [Abstract][Full Text] [Related]
13. Drug-loaded titanium dioxide nanoparticle coated with tumor targeting polymer as a sonodynamic chemotherapeutic agent for anti-cancer therapy.
Kim S; Im S; Park EY; Lee J; Kim C; Kim TI; Kim WJ
Nanomedicine; 2020 Feb; 24():102110. PubMed ID: 31666202
[TBL] [Abstract][Full Text] [Related]
14. Phenylboronic-acid-based nanocomplex as a feasible delivery platform of immune checkpoint inhibitor for potent cancer immunotherapy.
Lim J; Lee J; Jung S; Kim WJ
J Control Release; 2021 Feb; 330():1168-1177. PubMed ID: 33212120
[TBL] [Abstract][Full Text] [Related]
15. PVA reinforced gossypolone and doxorubicin π-π stacking nanoparticles towards tumor targeting and ultralow dose synergistic chemotherapy.
Liu Y; Li K; Wu Y; Ma J; Tang P; Liu Y; Wu D
Biomater Sci; 2019 Aug; 7(9):3662-3674. PubMed ID: 31179466
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
17. Tumor delivery of liposomal doxorubicin prepared with poly-L-glutamic acid as a drug-trapping agent.
Miatmoko A; Kawano K; Yoda H; Yonemochi E; Hattori Y
J Liposome Res; 2017 Jun; 27(2):99-107. PubMed ID: 26982164
[TBL] [Abstract][Full Text] [Related]
18. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug.
Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X
Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928
[TBL] [Abstract][Full Text] [Related]
19. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
Lale SV; R G A; Aravind A; Kumar DS; Koul V
Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
[TBL] [Abstract][Full Text] [Related]
20. pH/H
Wang Y; Wang J; Gou K; Kang W; Guo X; Zhu K; Li S; Li H
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35397-35409. PubMed ID: 34313104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
